Fighting cancer with cancer: new vaccine raises hope
Fighting cancer with cancer: new vaccine raises hope newspress_en Thu, 09/03/2026 - 15:10 Science & Technology Last month, two major pharmaceutical companies released cancer drug trial results that excited oncologists. The results showed that a vaccine can be designed from the genetic features of a patient’s own tumour and used to train their immune system to hunt down any malignant cells still…
Recent clinical trials of a personalized cancer vaccine have sparked optimism in the medical community. Developed by pharmaceutical giants Moderna and Merck, the vaccine employs a patient's own tumor genetic material to train the immune system to target residual malignant cells post-surgery. The announcement of the first-ever positive results from a Phase III trial occurred on August 19, 2025, signaling a potential breakthrough in treating high-risk melanoma, a prevalent form of skin cancer.
The vaccine relies on neoantigens, unique proteins formed due to cancer-specific DNA mutations. While the treatment remains experimental and not yet approved, oncologists are enthusiastic about its potential as a transformative cancer therapy.
Written by urgent.news from Al Majalla English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
